Novartis’s Ligelizumab Founders In Phase III Despite Positive Predictions

Fails To Top Xolair in CSU trials

 
• By Ayisha Sharma
  
CSU Causes Itchy, Painful Hives And Angioedema • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D